ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $370,000 | -5.9% | 24,948 | +0.0% | 0.00% | 0.0% |
| Q2 2022 | $393,000 | -41.5% | 24,937 | +0.0% | 0.00% | -33.3% |
| Q1 2022 | $672,000 | -27.1% | 24,936 | +0.0% | 0.00% | -25.0% |
| Q4 2021 | $922,000 | -22.6% | 24,925 | +0.0% | 0.00% | -33.3% |
| Q3 2021 | $1,191,000 | +41.3% | 24,920 | 0.0% | 0.01% | +50.0% |
| Q2 2021 | $843,000 | -18.1% | 24,920 | -0.0% | 0.00% | -33.3% |
| Q1 2021 | $1,029,000 | -9.7% | 24,925 | -5.1% | 0.01% | -14.3% |
| Q4 2020 | $1,139,000 | -6.5% | 26,266 | -7.5% | 0.01% | -12.5% |
| Q3 2020 | $1,218,000 | -12.0% | 28,396 | -4.1% | 0.01% | -20.0% |
| Q2 2020 | $1,384,000 | +244.3% | 29,600 | 0.0% | 0.01% | +233.3% |
| Q1 2020 | $402,000 | +24.8% | 29,600 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $322,000 | +5.9% | 29,600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $304,000 | +17.8% | 29,600 | +8.4% | 0.00% | 0.0% |
| Q2 2019 | $258,000 | – | 27,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |